YOLFTbeta
00

Qianjiang Yongan Pharmaceutical Co Ltd

002365 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

11.93CNY-0.29 (-2.37%)

Price History

Full chart

Market Stats

Previous Close12.22
Open12.15
Day Range11.84 – 12.24
52-Week Range9.82 – 19.72
Volume10.39M
Market Cap3.97B
P/E (TTM)74.89
Forward P/E33.44
EPS0.18
Dividend Yield0.77%
Beta0.32
50-Day Avg13.97
200-Day Avg13.63

About

Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces nutrition and health foods, water reducers and other related products, as well as customized services for nutrition and health intervention products. The company engages in scientific research and technical services, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Rengui Hong
  • Employees912
  • HeadquartersNo. 2 Guangze Avenue, Qianjiang, China, 433132, China
  • Websitehttps://www.chinataurine.com

Leadership

  • Mr. Rengui HongMD & Director · b. 1983
  • Mr. Shengjie XiongCFO & Secretary · b. 1968
  • Mr. Shi Hao DongDeputy General Manager · b. 1971
  • Mr. Xu WuSenior Management · b. 1978
  • Mr. Xiquan FangDeputy General Manager · b. 1964
  • Mr. Zhihua WangDeputy General Manager · b. 1970
  • Mr. Shaobo LiSenior Management · b. 1987
  • Mr. Wei YeDeputy General Manager · b. 1984
  • Mr. Wei DongSenior Management · b. 1990
  • Ms. Yong Hong DengSenior Management · b. 1981

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue156.70M314.99M447.49M310.30M319.73M417.01M470.70M522.72M658.42M555.89M549.40M932.77M1.01B1.37B1.17B1.57B1.46B972.89M838.81M783.17M
Growth (%)-+101.01%+42.07%-30.66%+3.04%+30.43%+12.87%+11.05%+25.96%-15.57%-1.17%+69.78%+7.79%+36.31%-14.42%+33.47%-6.58%-33.48%-13.78%-6.63%
Cost of Revenue101.32M209.97M284.42M207.58M239.39M314.44M343.41M438.51M557.65M461.03M408.54M594.55M655.79M1.05B820.06M1.21B991.13M722.37M672.79M650.68M
Gross Profit55.38M105.02M163.06M102.72M80.34M102.58M127.29M84.20M100.76M94.86M140.86M338.22M349.61M317.63M352.80M353.73M471.32M250.52M166.02M132.48M
Gross Margin35.34%33.34%36.44%33.10%25.13%24.60%27.04%16.11%15.30%17.06%25.64%36.26%34.77%23.18%30.08%22.60%32.23%25.75%19.79%16.92%
Operating Expense16.84M33.94M43.32M30.12M33.53M24.59M51.26M61.78M68.03M81.47M78.29M186.40M137.32M200.01M218.82M222.07M318.92M244.87M93.09M135.20M
Operating Income38.54M71.08M119.75M72.60M46.82M77.98M76.03M22.42M32.73M13.40M62.57M151.82M212.29M117.62M133.97M131.67M152.40M5.65M72.93M-2.72M
Operating Margin24.60%22.57%26.76%23.40%14.64%18.70%16.15%4.29%4.97%2.41%11.39%16.28%21.12%8.58%11.42%8.41%10.42%0.58%8.69%-0.35%
EBITDA40.77M81.80M127.54M85.71M65.02M97.44M108.14M68.41M93.95M98.00M152.79M226.86M291.87M229.70M245.33M248.53M277.35M141.86M184.33M127.66M
EBITDA Margin26.02%25.97%28.50%27.62%20.34%23.37%22.97%13.09%14.27%17.63%27.81%24.32%29.03%16.76%20.92%15.88%18.96%14.58%21.98%16.30%
Net Income37.46M68.95M102.58M65.05M46.11M69.77M75.36M23.01M31.72M17.61M62.30M133.15M178.58M89.93M105.56M111.42M140.35M-12.31M61.77M22.49M
Net Income Margin23.91%21.89%22.92%20.96%14.42%16.73%16.01%4.40%4.82%3.17%11.34%14.27%17.76%6.56%9.00%7.12%9.60%-1.27%7.36%2.87%
R&D-217.00K421.54K369.81K--19.84M23.45M23.59M23.35M21.82M29.28M23.98M54.42M46.66M53.04M40.45M41.50M36.97M30.88M
R&D as % of Total Revenue-0.07%0.09%0.12%--4.21%4.49%3.58%4.20%3.97%3.14%2.39%3.97%3.98%3.39%2.77%4.27%4.41%3.94%
Interest Expense991.00K3.48M351.39K267.91K273.32K340.56K550.11K348.15K322.94K7.36M256.87K511.29K467.19K587.65K1.68M2.72M947.49K627.27K795.03K941.51K
Interest Expense % of Total Revenue0.63%1.10%0.08%0.09%0.09%0.08%0.12%0.07%0.05%1.32%0.05%0.05%0.05%0.04%0.14%0.17%0.06%0.06%0.09%0.12%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets151.23M254.42M379.16M394.00M1.09B1.16B1.21B1.20B1.19B1.20B1.27B1.58B1.93B1.91B2.16B2.29B2.42B2.35B2.31B2.20B
Total Liabilities46.24M62.89M120.04M69.83M76.14M104.13M116.59M122.50M79.14M83.50M96.22M235.23M323.11M251.14M349.92M328.95M321.17M298.85M266.55M218.72M
Total Equity104.99M191.53M259.12M324.17M1.01B1.06B1.09B1.08B1.11B1.12B1.17B1.34B1.58B1.61B1.76B1.87B2.02B1.98B1.99B1.99B
Cash16.66M37.87M121.29M76.74M517.59M227.26M220.82M124.13M30.63M59.40M89.01M132.36M22.96M117.33M114.20M93.51M274.72M326.17M320.41M230.59M
Total Debt----------10.06M126.99M2.00M3.00M122.35M20.38M40.01M10.01M39.53M-
Net Debt-16.66M-37.87M-121.29M-76.74M-517.59M-227.26M-220.82M-124.13M-30.63M-59.40M-78.95M-5.37M-20.96M-114.33M8.15M-73.13M-234.70M-316.16M-280.88M-

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow31.11M61.08M158.47M36.43M44.06M91.23M70.75M63.65M19.26M70.61M84.53M197.32M314.02M239.55M206.66M101.81M387.28M244.26M105.71M139.08M
Investing Cash Flow-17.45M-49.11M-72.19M-45.98M-262.55M-341.42M-39.81M-120.90M-107.16M-35.29M-61.70M-248.54M-408.55M-47.44M-331.08M21.83M-230.40M-166.05M-47.38M-
Financing Cash Flow-6.18M9.24M-2.86M-35.00M649.86M-30.51M-37.37M-39.38M-5.61M-6.72M-7.55M111.18M-15.97M-99.15M122.43M-139.25M17.81M-65.77M-37.40M-
Capital Expenditure17.68M60.77M72.19M45.98M104.52M248.03M120.18M99.93M50.69M34.12M40.13M289.47M269.50M134.39M104.41M63.05M149.07M120.74M118.04M62.28M
Free Cash Flow13.44M307.69K86.28M-9.55M-60.45M-156.80M-49.43M-36.28M-31.42M36.49M44.40M-92.15M44.53M105.15M102.25M38.76M238.21M100.46M-12.33M76.81M
Dividends Paid177.43K12.74M2.86M35.00M42.35M30.51M37.37M39.38M5.61M11.22M5.61M18.83M19.65M29.47M43.08M29.43M1.57M29.47M29.82M29.88M
FCF to OCF43.18%0.50%54.45%-26.21%-137.20%-171.87%-69.87%-57.00%-163.13%51.68%52.53%-46.70%14.18%43.90%49.48%38.07%61.51%41.13%-11.66%55.22%
Dividend Paid to FCF1.32%4138.92%3.31%-366.62%-70.05%-19.46%-75.61%-108.54%-17.85%30.75%12.63%-20.43%44.14%28.02%42.13%75.92%0.66%29.33%-241.80%38.91%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Aug 21, 2014Oct 28, 2014Feb 27, 2015Apr 22, 2015Aug 26, 2015Oct 27, 2015Feb 26, 2016Apr 22, 2016Aug 19, 2016Oct 26, 2016Feb 23, 2017Apr 26, 2017Aug 17, 2017Oct 24, 2017Feb 9, 2018Apr 27, 2018Aug 20, 2018Oct 19, 2018Mar 27, 2019Apr 23, 2019Aug 24, 2019Oct 25, 2019Feb 28, 2020Apr 27, 2020Aug 26, 2020Oct 22, 2020Mar 30, 2021Apr 24, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Jun 21, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025
EPS Estimate-------------------------------------------------------------
EPS Actual0.060.030.040.030.040.080.070.050.050.090.070.060.040.030.02-0.010.010.060.040.000.020.020.02-0.000.030.090.060.040.090.150.170.040.160.120.160.090.020.090.130.070.020.300.07-0.030.030.130.120.100.170.220.15-0.070.050.14-0.03-0.200.100.080.03-0.00-0.02
Surprise-------------------------------------------------------------
Timing-----------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-market------------After-hours----

Key Statistics & Ratios

Market Cap3.97B
Enterprise Value3.24B
Trailing P/E74.89
Forward P/E33.44
PEG Ratio0.00
Price / Sales4.06
Price / Book2.04
EPS0.18
Book Value6.93
Revenue (TTM)979.49M
Gross Profit (TTM)216.18M
EBITDA170.72M
Profit Margin5.45%
Operating Margin14.49%
Return on Equity2.07%
Return on Assets1.52%
Shares Outstanding294.68M
Shares Float207.60M
Beta0.32
Dividend Yield0.77%
Dividend Rate0.10
Payout Ratio108.34%

Dividends

20261×
0.10Jun 11, 2026
20251×
0.10Jul 9, 2025
20241×
0.10Jul 5, 2024
20231×
0.10Jul 5, 2023
20211×
0.10Jul 9, 2021
20201×
0.15May 29, 2020
20191×
0.10May 27, 2019
20181×
0.07May 15, 2018
20171×
0.07Jun 9, 2017
20161×
0.02Aug 11, 2016
20151×
0.04Jul 15, 2015
20141×
0.02Jun 13, 2014
20131×
0.13May 15, 2013
20121×
0.13Jun 18, 2012
20111×
0.10May 3, 2011
20101×
0.17Sep 21, 2010

Stock Splits

  • May 15, 20181.5:1
  • May 3, 201120:10